Log in to save to my catalogue

Re-evaluation of controversial issues in the treatment of cT3N0-2 rectal cancer: a 10-year cohort an...

Re-evaluation of controversial issues in the treatment of cT3N0-2 rectal cancer: a 10-year cohort an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2596950676

Re-evaluation of controversial issues in the treatment of cT3N0-2 rectal cancer: a 10-year cohort analysis using propensity-score matching

About this item

Full title

Re-evaluation of controversial issues in the treatment of cT3N0-2 rectal cancer: a 10-year cohort analysis using propensity-score matching

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

International journal of colorectal disease, 2021-12, Vol.36 (12), p.2649-2659

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Although neoadjuvant treatment is thought to provide optimal local control for stage II and III rectal cancers, many patients have been reported cured by total mesorectal excision (TME), alone or with additional chemotherapy (CTX).
Methods
This study retrospectively evaluated outcomes in 2643 patients with cT3N0-2 rectal cancers...

Alternative Titles

Full title

Re-evaluation of controversial issues in the treatment of cT3N0-2 rectal cancer: a 10-year cohort analysis using propensity-score matching

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2596950676

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2596950676

Other Identifiers

ISSN

0179-1958

E-ISSN

1432-1262

DOI

10.1007/s00384-021-04003-8

How to access this item